Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
361 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (2)
  • Closed (1)

Medical Condition

  • Show all (123)
  • Allergy, Asthma, & Immunology (1)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (6)
  • Bone & Muscle (1)
  • Cancer (73)
    • Brain Cancer (2)
    • Breast Cancer (1)
    • Head and Neck Cancer (1)
    • Kidney Cancer (1)
    • Leukemia (2)
    • (-) Lung Cancer (1)
    • Lymphoma (6)
    • Pancreatic Cancer (1)
    • Prostate Cancer (1)
    • Sarcoma (1)
    • Skin Cancer (30)
    • Solid Tumors (3)
  • COVID-19 (Coronavirus) (2)
  • Diabetes (1)
  • (-) Hair and Skin Disorders (2)
  • Healthy Volunteers (11)
  • Heart Disease (3)
  • Infectious Disease (1)
  • Kidney Disease (1)
  • Lung Disease (5)
  • Neurological Disorders (4)
  • Obstetrics & Gynecology (2)
  • Pediatrics (4)
  • Psychiatric Disorders (1)
  • Rehabilitation (1)
  • Transplant (2)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

Collection of Blood and Skin Samples from Patients with Hair and Skin Disorders

Condition: Hair and Skin Disorders
Investigator: Angela Christiano, PhD
Status: Currently Recruiting
The purpose of this study is to examine the causes and pathology of alopecia areata and other hair and skin disorders. Skin biopsies and blood and/or clinical information collected in the study will be used for research aiming at developing new options for the treatment of alopecia areata and…
Read More

Genetic Studies of Hidradenitis Suppurativa

Condition: Hair and Skin Disorders
Investigator: Lynn Petukhova, PhD
Status: Closed
Genetic studies help us to understand why some people develop certain diseases while others don't and also provide important clues about how best to treat the disease.
Read More

COPERNICUS: A study to treat non-small cell lung cancer (NSCLC)

Condition: Cancer / Lung Cancer
Investigator: Catherine Shu, MD
Status: Currently Recruiting
The purpose of this study is to understand more about the combination of amivantamab and lazertinib in non-small cell lung cancer (NSCLC) who have a specific mutation in the EGFR (epidermal growth factor receptor) gene and have not had prior treatment for their disease. The Food and Drug Administration (FDA) has not approved the combination of amivantamab…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science